Although an increased incidence of de novo malignancies is reported in transplant recipients, rhabdomyosarcoma, an aggressive mesenchymal tumor typical of childhood, is not considered a neoplasm commonly related to immunosuppression. A 21-year-old woman presented with unilateral diplopia and proptosis 16 months after liver transplantation for fulminant hepatic failure. A tumoral mass originating from the medial rectus muscle was partially removed and diagnosed as being an embryonal rhabdomyosarcoma. Since the patient refused complete orbital excision, one course of radiotherapy and six courses of chemotherapy were administered, while immunosuppression was re-modulated, without interruption of the administration of cyclosporine. Complete control of tumor growth was achieved, while no alterations of graft function were observed throughout the treatment period.

Embryonal rhabdomyosarcoma of the orbit in a liver transplant recipient / CESCON M; GRAZI G; ASSETTI R; SCANNI A; FRIGERIO F; SPARACIO F; ERCOLANI G; CAVALLARI A. - In: TRANSPLANT INTERNATIONAL. - ISSN 0934-0874. - STAMPA. - 16:(2003), pp. 437-440. [10.1111/j.1432-2277.2003.tb00327.x]

Embryonal rhabdomyosarcoma of the orbit in a liver transplant recipient

GRAZI G;
2003

Abstract

Although an increased incidence of de novo malignancies is reported in transplant recipients, rhabdomyosarcoma, an aggressive mesenchymal tumor typical of childhood, is not considered a neoplasm commonly related to immunosuppression. A 21-year-old woman presented with unilateral diplopia and proptosis 16 months after liver transplantation for fulminant hepatic failure. A tumoral mass originating from the medial rectus muscle was partially removed and diagnosed as being an embryonal rhabdomyosarcoma. Since the patient refused complete orbital excision, one course of radiotherapy and six courses of chemotherapy were administered, while immunosuppression was re-modulated, without interruption of the administration of cyclosporine. Complete control of tumor growth was achieved, while no alterations of graft function were observed throughout the treatment period.
2003
16
437
440
CESCON M; GRAZI G; ASSETTI R; SCANNI A; FRIGERIO F; SPARACIO F; ERCOLANI G; CAVALLARI A
File in questo prodotto:
File Dimensione Formato  
Transplant International - 2005 - Cescon.pdf

Accesso chiuso

Dimensione 645.24 kB
Formato Adobe PDF
645.24 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1301227
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 4
social impact